Citic Securities Company Limited(600030)
About Suzhou Nanomicro Technology Co.Ltd(688690)
2021 continuous supervision and tracking report
Citic Securities Company Limited(600030) (hereinafter referred to as ” Citic Securities Company Limited(600030) ” or “sponsor”) as the sponsor of Suzhou Nanomicro Technology Co.Ltd(688690) (hereinafter referred to as ” Suzhou Nanomicro Technology Co.Ltd(688690) ” or “company”) initial public offering of shares and listing on the science and innovation board, in accordance with the measures for the administration of securities issuance and listing sponsor business and the rules for the listing of shares on the science and Innovation Board of Shanghai Stock Exchange (revised in December 2020) Responsible for the continuous supervision after Suzhou Nanomicro Technology Co.Ltd(688690) listing and Issuing the annual follow-up report of continuous supervision according to relevant provisions such as the guidelines for self discipline supervision of companies listed on the science and Innovation Board of Shanghai Stock Exchange No. 1 – standardized operation and the measures for continuous supervision of companies listed on the science and innovation board (for Trial Implementation). 1、 Continuous supervision
No. work content and continuous supervision
1. Establish, improve and effectively implement the continuous supervision system, and the sponsor has established, improved and effectively implemented the continuous supervision system, formulated the corresponding work plan for the specific continuous supervision work, and formulated the corresponding work plan
According to the relevant provisions of the CSRC, in the process of continuous supervision, the sponsor has signed the continuous supervision recommendation agreement with the listed company or relevant parties before the commencement of underwriting and underwriting 2 with Suzhou Nanomicro Technology Co.Ltd(688690) Suzhou Nanomicro Technology Co.Ltd(688690) , which has defined the agreement between the two parties during the continuous supervision, the rights and obligations of both parties during the continuous supervision, and the rights and obligations of both parties, It has been reported to Shanghai Stock Exchange and Shanghai stock exchange for the record
Through daily communication, regular return visit, on-site inspection and due diligence, the recommendation institution understands the continuous supervision of Suzhou Nanomicro Technology Co.Ltd(688690) business operation investigation through daily communication, regular and irregular 3 return visit, and carries out continuous supervision on Suzhou Nanomicro Technology Co.Ltd(688690) business
During the period of continuous supervision, in accordance with relevant regulations, Suzhou Nanomicro Technology Co.Ltd(688690) in the period of this continuous supervision follow-up report, make a public statement on the 4 violations of the listed company, which shall be reported to Shanghai Securities Regulatory Commission before disclosure
After the report of the stock exchange and the examination of the Shanghai Stock Exchange, there is no violation of laws and regulations that must be declared in the announcement form on the designated media of the public development of the recommendation institution according to relevant regulations
During the period of continuous supervision, the listed company or relevant parties violate the regulations
In case of violation of laws, breach of commitments and other matters, it shall be found or
Report to the Shanghai Stock Exchange Suzhou Nanomicro Technology Co.Ltd(688690) within five working days from the date of discovery. During this continuous supervision period, there are no 5 reports, including violations of laws and regulations or breach of commitments by the listed company or relevant parties
The specific conditions of violations of laws and regulations, breach of commitments and other matters shall be guaranteed
Supervision measures taken by the recommender, etc
During this continuous supervision period, the sponsor supervised nanomicro to supervise listed companies and their directors, supervisors and senior managers, and technology and its directors, supervisors and senior managers 6 to abide by laws, regulations and departmental rules, and Shanghai Stock Exchange to abide by laws, regulations and departmental rules, as well as the business rules and other normative documents issued by Shanghai Securities, And earnestly fulfill the business rules and other normative documents issued by the stock exchange, and earnestly fulfill the commitments made by it
Supervise listed companies to establish, improve and effectively implement the corporate governance system for seven times, including but not limited to the general meeting of shareholders, the board of directors and the board of supervisors, and the recommendation institutions urge Suzhou Nanomicro Technology Co.Ltd(688690) to further improve the rules of procedure and the corporate governance system of directors, supervisors and senior managers and implement them strictly
For specifications, etc
Supervise listed companies to establish, improve and effectively implement internal control systems,
Including but not limited to financial management system, accounting system and recommendation institution urging Suzhou Nanomicro Technology Co.Ltd(688690) to further improve the company’s internal audit system, as well as the use of raised funds and related party transactions
8. Internal control system of the company and its standardized operation
E-commerce, foreign guarantee, foreign investment, derivatives trading, counterparties
Procedures and rules for major business decisions such as the company’s control, etc
Urge listed companies to establish, improve and effectively implement the information disclosure system
Degree, review the information disclosure documents and other relevant documents, and have the sponsor urge Suzhou Nanomicro Technology Co.Ltd(688690) to further improve the letter 9. There are sufficient reasons to believe that the listed company’s interest rate disclosure system to Shanghai Stock Exchange is strictly implemented, and the documents submitted by the sponsor are free of false records, misleading statements or major disclosure documents
Omission
Information disclosure documents of listed companies and reports to the CSRC
Other documents submitted by Shanghai Stock Exchange shall be examined in advance
Read and urge the company to timely supervise the information disclosure documents with problems
If it is corrected or supplemented, and the company does not correct or supplement, it shall
Report to Shanghai Stock Exchange in time; If the credit recommendation institution of the listed company fails to review the information disclosure document of Suzhou Nanomicro Technology Co.Ltd(688690) in advance, it shall review the information disclosure document in time before or after the listed company, and complete the review of the relevant documents that should be reported to Shanghai Stock Exchange in time within five trading days after the listed company does not fulfill the obligation of information disclosure, Disclosure of problematic information
The listed company shall be urged to correct or supplement the documents in time
If it is not corrected or supplemented, it shall report to the Shanghai Stock Exchange in time
report
Listed companies or their controlling shareholders, actual controllers, directors
During the period of continuous supervision by the administrative office of the CSRC, Suzhou Nanomicro Technology Co.Ltd(688690) and its 11 fines, disciplinary actions by the Shanghai Stock Exchange, or regulatory concern letters issued by Shanghai stock shareholders, actual controllers, directors, supervisors and the exchange, And urge them to complete the internal control system in the absence of the above matters among senior managers, and take measures to correct them
Continue to pay attention to the performance of Suzhou Nanomicro Technology Co.Ltd(688690) and its controlling shareholders, actual controllers, etc. during the continuous supervision period. If the listed company, its controlling shareholders, actual shareholders and actual controllers do not fail to fulfill their commitments, they shall report to Shanghai Securities Regulatory Commission in time
The situation of Nuo
Stock exchange report
Pay attention to the reports of public media on listed companies and timely target them
Check market rumors.
After verification, if it is found that the listed company has any major matters that should be disclosed but not disclosed or the information that should be disclosed is not inconsistent with the facts that should be reported to the Shanghai Stock Exchange after verification by the recommendation institution, the listed company shall be urged to disclose or disclose them truthfully in time
To clarify; If a listed company does not disclose or clarify, it shall report the situation in a timely manner
Report to Shanghai Stock Exchange
Under any of the following circumstances, the listed company shall be urged to make explanations
And make corrections within a time limit and report to the Shanghai Stock Exchange:
(I) suspected of violating the listing rules and other relevant business regulations
Then; (II) the 14 professional opinions issued by the securities service institution and its signers may contain false records, misleading statements or important information. During the continuous supervision, Suzhou Nanomicro Technology Co.Ltd(688690) there are no violations of laws and regulations such as major omissions or other improper situations; The foregoing
(III) the company appears in articles 71 and 72 of the recommendation measures
Circumstances stipulated in Article 72; (IV) the company does not cooperate continuously
Supervision; (V) subscription by Shanghai Stock Exchange or sponsor
For other situations that need to be reported, 15 formulate the on-site inspection work plan for the listed company, clarify the relevant on-site inspection requirements that the sponsor has formulated, ensure the on-site inspection quality plan, and clarify the specific inspection requirements
The sponsor shall be aware of any of the following circumstances in the above-mentioned company:
Within 15 days from the date of knowing or should know, or Shanghai Securities Exchange
Carry out special on-site inspection on listed companies within the required time limit
Check: (I) controlling shareholders, actual controllers or other related parties
Non operating occupation of the funds of the listed company by the party; (II) violation means that Suzhou Nanomicro Technology Co.Ltd(688690) no one else provides guarantee during the continuous supervision; (III) illegal use of raised funds;
16 the foregoing
(IV) conduct securities investment and hedging business in violation of regulations;
(V) related party transactions are obviously unfair or fail to perform the approval procedures and procedures
Information disclosure obligations; (VI) loss of performance or operating profit
The profit decreased by more than 50% over the same period of last year; (VII) Shanghai certificate
Other circumstances required by the stock exchange
2、 Problems found and rectified by the sponsor and the sponsor’s representative
During the continuous supervision, the recommendation institution and the recommendation representative did not find any major problems in Suzhou Nanomicro Technology Co.Ltd(688690) the company. 3、 Major risk matters
During this continuous supervision period, the main risk items of the company are as follows: (I) core competitiveness risk
1. Risk of failure in research and development of new products or failure in industrialization
High performance microsphere materials are indispensable basic materials in the fields of biomedicine, flat panel display, analysis and detection and in vitro diagnosis. Their preparation and application involve multi-disciplinary knowledge and cutting-edge technologies such as chemistry, physics, biology and materials. The technical threshold and barrier are relatively high and the research and development cycle is long. Therefore, the research and development of new products requires a lot of manpower, material resources and capital investment. In order to maintain its competitive advantage, the company needs to constantly develop new technologies and market transformation to enrich its product line, and actively explore new application fields and expand the market scale. Under the background that enterprises in the same industry generally increase R & D investment, while foreign manufacturers start earlier, have larger scale and stronger capital strength, the company may fail in technology development or fail to industrialize research projects due to uncertain factors such as R & D conditions and industrialization process management, resulting in the failure to launch new products on the market as planned, It will have an adverse impact on the growth of the company’s operating revenue and the improvement of its profitability. During the reporting period, the company’s R & D investment accounted for 14.81% of the operating revenue, and the R & D investment accounted for a relatively high proportion. If the R & D and industrial application of new products fail, or the market sales fail to meet the expectations, it will have an adverse impact on the company’s financial situation and production and operation.
2. Risk of important proprietary technology being plagiarized or copied
The chromatographic packing / chromatographic medium industry of the company is a technology intensive industry and has been monopolized by large international technology companies for a long time. As a late developing domestic manufacturer, the company mainly relies on core technology to carry out production and operation and participate in market competition, and wins market share by virtue of the comparative advantages of technology and products. For the core technology with important commercial significance, the company protects it through patent application, technical secret and other methods, but there may still be the risk of intellectual property infringement or inadequate protection. The disclosure of the company’s core technology or the infringement of the company’s proprietary technology by a third party may lead to the infringement of the company’s core competitiveness.
3. Risk of loss of core technicians and other important R & D personnel
The company’s R & D team plays a key role in the company’s R & D and production process and is crucial to the company’s future development. As an innovation driven start-up company, if it cannot continue to provide competitive treatment in terms of salary and welfare, working environment and career development in the future and continuously improve the incentive mechanism, it may cause the instability of the company’s R & D team and even lead to the loss of core technicians and other important R & D personnel, which will have an adverse impact on the company’s business and long-term development. (II) operational risk
1. Risk of stable supply of raw materials
As the main application field of the company’s high-performance microsphere materials is the biopharmaceutical industry, its production and preparation requires high technical stability and raw material quality, and some downstream biopharmaceutical customers will also require the company to report the replacement information of raw materials to it in time. Due to the small production and operation scale of the company, in order to improve the bargaining power and reduce the procurement cost, the company adopts the centralized procurement strategy for some raw materials to obtain price concessions. Therefore, there is a single supplier procurement situation. If there is a problem with the raw material supply of a single purchasing supplier, the company needs to purchase from other alternative suppliers and re conduct the product verification procedure if necessary, which may increase the cost of product quality control in the short term and have a certain adverse impact on the production progress and sales of products.
The main raw and auxiliary materials purchased by the company include chemical raw materials, packaging materials, chemical reagents for production and R & D, consumables, etc. The purchase price of such materials mainly depends on the product pricing of the manufacturer and the market supply and demand at the purchase time point. The company has little influence on the purchase price of the above raw materials; The preparation cycle of such materials is generally 7-15 working days, and the preparation cycle of imported raw materials is generally 45-60 days. The company may have the risk of affecting the production progress due to the change of the supply cycle of main raw materials, or increasing the cost due to the large fluctuation of the price of raw materials.
2. Risk of intensified market competition
With the rapid growth of China’s biopharmaceutical market and the successful listing of the company on the science and innovation board, the subdivided field of drug separation and purification has received higher attention and attention. Large multinational companies that have monopolized the supply of chromatographic fillers / chromatographic media pay more attention to the business in the Chinese market, while Chinese companies in the same industry are also easier to obtain equity financing and speed up development than ever before, and the company is facing the risk of intensified market competition. The application of chromatographic packing / chromatographic medium in the field of biomedicine requires in-depth cooperation between the supplier and the demander in the optimization of separation and purification process, and the downstream pharmaceutical customers need to fully trust the company’s product quality and application scheme. Compared with the competitors of multinational corporations, the company has a significant gap in brand influence, which makes the company
